Zoetis Inc. (ZTS)
NYSE: ZTS · Real-Time Price · USD
167.14
+1.74 (1.05%)
At close: May 29, 2025, 4:00 PM
166.85
-0.29 (-0.18%)
After-hours: May 29, 2025, 7:00 PM EDT
Zoetis Revenue
Zoetis had revenue of $2.22B in the quarter ending March 31, 2025, with 1.37% growth. This brings the company's revenue in the last twelve months to $9.29B, up 6.32% year-over-year. In the year 2024, Zoetis had annual revenue of $9.26B with 8.33% growth.
Revenue (ttm)
$9.29B
Revenue Growth
+6.32%
P/S Ratio
8.13
Revenue / Employee
n/a
Employees
n/a
Market Cap
74.41B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.26B | 712.00M | 8.33% |
Dec 31, 2023 | 8.54B | 464.00M | 5.74% |
Dec 31, 2022 | 8.08B | 304.00M | 3.91% |
Dec 31, 2021 | 7.78B | 1.10B | 16.49% |
Dec 31, 2020 | 6.68B | 415.00M | 6.63% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ZTS News
- 10 hours ago - Zoetis Inc. (ZTS) Stifel 2025 Jaws & Paws Conference (Transcript) - Seeking Alpha
- 7 days ago - Dr. Mark Stetter Elected to Zoetis Board of Directors - Business Wire
- 8 days ago - Zoetis Declares Third Quarter 2025 Dividend - Business Wire
- 14 days ago - Zoetis to Participate in Upcoming Investor Conferences - Business Wire
- 20 days ago - Zoetis' Q1: Market Overreaction Or Justified Drop? - Seeking Alpha
- 21 days ago - Zoetis: Solid Q1 Results And A Weaker Dollar Provide Support (Upgrade) - Seeking Alpha
- 23 days ago - Zoetis Inc. (ZTS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Zoetis raises forecast for 2025 revenue, profit on weaker US dollar - Reuters